Name: Insight Molecular Diagnostics Inc. (IMDX) Balance Sheet
Creator: FinSpry

Insight Molecular Diagnostics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Insight Molecular Diagnostics Inc. (IMDX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	8.64	9.43	19.99	32.95	7.14
Short-Term Investments	0.00	0.00	0.43	0.90	0.68
Cash & Short-Term Investments	8.64	9.43	20.43	33.85	7.82
Accounts Receivable	1.61	0.48	2.01	1.44	0.20
Inventory	0.41	0.00	0.00	0.30	0.00
Other Current Assets	0.82	0.64	0.98	0.90	0.26
Total Current Assets	11.76	10.70	25.54	39.14	9.23
Non-Current Assets
Property, Plant & Equipment (Net)	6.32	5.44	10.85	8.37	6.52
Long-Term Investments	1.70	0.00	0.00	0.00	13.42
Goodwill	0.00	0.00	0.00	18.68	9.19
Intangible Assets	14.61	56.60	61.63	61.72	15.01
Other Non-Current Assets	2.39	2.16	2.07	31.65	2.06
Total Non-Current Assets	23.32	64.19	74.56	120.42	0.00
Total Assets	35.08	74.89	100.09	159.56	55.42
Current Liabilities
Accounts Payable	2.28	0.95	1.25	1.81	0.43
Short-Term Debt	1.30	0.00	0.00	1.31	2.39
Current Portion of Long-Term Debt	0.00	0.00	0.00	1.31	2.39
Accrued Liabilities	1.53	3.22	3.95	3.47	5.75
Other Current Liabilities	0.23	2.36	2.01	1.53	0.00
Total Current Liabilities	7.28	7.19	12.11	14.12	9.00
Non-Current Liabilities
Long-Term Debt	2.37	2.20	2.73	3.55	1.51
Other Non-Current Liabilities	37.71	39.90	45.66	76.68	7.12
Total Non-Current Liabilities	40.08	47.23	53.69	80.23	0.00
Total Liabilities	47.36	49.30	65.80	94.35	21.94
Stockholders' Equity
Common Stock	338.24	310.30	294.93	252.95	157.16
Retained Earnings	-350.54	-289.88	-260.68	-187.77	-123.68
Accumulated Other Comprehensive Income	0.02	0.05	0.04	0.04	0.00
Shares Outstanding	17.45	8.26	5.93	4.61	0.00
Total Stockholders' Equity	-12.27	25.59	34.29	65.22	33.48
Total Liabilities & Equity	35.08	74.89	100.09	159.56	0.00